ArticleJournal of thoracic disease2020

Does neoadjuvant targeted therapy provide an opportunity for resectable EGFR-mutant lung cancer: a real-world retrospective study.

Chao Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.